Maybe its contaminated is the part you dont get to hand-wave away
BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
Use finasteride or dutasteride only as prescribed
The standard dosage is 2,000 to 2,500 mcg of total blend injected subcutaneously once daily for 4 weeks, followed by 2 to 4 weeks off
Collectively, the findings demonstrated that BPC157 has significant mitigating effects against cancer cachexia-induced muscle degeneration, inflammation, and catabolism